 Monosodium glutamate (MSG) is a suspected obesogen.
catering and food production. Recently it has been highlighted as a suspected dietary obesogen in epidemiological studies indicating a link between MSG consumption and weight gain. Additionally, animal studies have shown that MSG exposure has profound effects on sex steroid hormone levels and receptors; which have an important role in energy metabolism. However, the exact mechanism by which MSG exerts its effects has yet to be elucidated. Reporter gene assays (RGAs) and the H295R steroidogenesis assay have been used to investigate the endocrine disrupting potential of MSG. Receptor (ant) agonism was not observed in the MMV-Luc (oestrogen responsive) or TM-Luc (progestagen responsive) cell lines following exposure to MSG. Also, no effects on hormone production were observed. However, MSG exhibited an antagonist response in the androgen and progestagen responsive TARM-Luc cell line, with a dose dependent reduction in androgen response of 33%, 36.9% and 50.6% (in comparison to the solvent control) at 50, 250 and 500 µg/ml MSG, respectively (P ≤ 0.05; P ≤ 0.05; P ≤ 0.001). No cytotoxicity or pre lethal cytotoxicity was observed at the concentrations tested. These findings demonstrate one potential pathway whereby MSG may act as a dietary obesogen.
Abbreviations: ADI; Acceptable Daily Intake, ANOVA; a one-way analysis of variance, AR; androgen receptor, dH20; deionised water, DMSO; dimethyl sulfoxide, EAAT-1; excitatory amino acid transporter, EDCs; endocrine disrupting compounds, EFSA; European Food A C C E P T E D M A N U S C R I P T
Introduction
Obesity is a global health problem, with an estimated 640 million adults in 2014 and 110 million children and adolescents in 2013 being classed as obese (Lauby-Secretan et al., 2016) . Although body fatness and weight gain are largely influenced by modifiable risk factors such as food consumption and exercise, further factors such as exposure to pesticides and/or persistent organic pollutants (POPs) in food or the environment may be involved (Lauby-Secretan et al. 2016) . In particular, endocrine disrupting compounds (EDCs), which are exogenous substances or mixtures that alter the function(s) of the endocrine system and consequently cause adverse health effects in an intact organism, or its progeny, or (sub)populations (WHO/IPCS, 2002) , have been linked to obesity (Legler et al., 2011) .
EDCs whose effects may result in metabolic disorders are termed "obesogens" or metabolic disruptors. Obesogens may act by altering the programming of adipogenesis and increasing energy storage in fat tissue, or by disrupting the neuroendocrine control of appetite and satiety (Janesick and Blumberg, 2016) .
Environmental exposures during early life can interfere with the epigenetic programming of gene regulation, leading to potential transgenerational effects and
influencing the risk of obesity in adulthood via adipogenesis, adiposity and body weight gain (Stel and Legler, 2015) . In addition, steroid hormones and their receptors have also been linked to the homeostasis of energy metabolism (Mauvais-Jarvis, 2011).
A suspected dietary obesogen which is a widely consumed flavour enhancer is monosodium glutamate (MSG). MSG is composed of sodium mineral ion or salt, attached to glutamic acid, one of the most abundant naturally occurring nonessential amino acids naturally present in our bodies and many foods such as mushrooms, tomatoes and cheese. Once ingested, MSG is broken down into glutamate and sodium ions within the digestive tract and metabolised within the gut.
The glutamate that is absorbed, is then transported in the lumen of the intestine through the EAAC-1 (the EAAT-1 or excitatory amino acid transporter) and NaDC-1 (sodium carboxylate transporter) and circulated in the bloodstream throughout the body (Burrin and Stoll, 2009; Janeczko et al., 2007) .
MSG is now a relevant aspect of the human diet worldwide. The UK average intake in 1991 was 580 mg/day for the general population but 2.3 g/day for excessive consumers (Rhodes et al., 1991) . More recent studies report an average intake of MSG of 0.4 g/day in European countries (Beyreuther et al., 2007) . In countries such as China, mean MSG consumption has been found to be higher, around 3.1 g/day (Shi et al., 2014) . In an EFSA report released in 2017, an ADI (acceptable daily intake) of 30 mg/kg bw per day, was set. Accurately monitoring levels of MSG consumption is difficult because legislation does not enforce any limit on the amount of MSG that restaurants or the food industry can add to their products. Also, food processors and manufacturers are not obligated to list the amount of MSG on their packaging (Food Standards, 2015) .
The mechanism by which MSG may act as an obesogen has not been yet been elucidated (He et al., 2008; He et al., 2011; Khalaf and Arafat, 2015; Miskowiak et al., 1993) . In vivo studies link MSG intake to disruption of steroid receptor expression and alteration of levels of hormones such as oestrogen, testosterone or progesterone (Zia et al., 2014; Miskowiak et al., 1993; Rodriguez-Sierra et al., 1982; Nemeroff et al., 1981) . These studies demonstrate that MSG may disrupt steroid hormone receptors and/or steroid hormone levels.
We have previously shown that MSG decreases glucagon-like peptide 1 (GLP-1) secretion in a gut in vitro cellular model (Shannon et al., 2017) , suggesting a possible mechanism by which MSG may affect glucose regulation and satiety responses.
Additionally, as discussed above, studies have demonstrated that MSG may affect sex hormone levels and receptors in vivo. As steroid hormones/receptors play an important role in weight homeostasis, the present study was performed to investigate the potential endocrine disrupting mechanisms of MSG at the level of nuclear receptor transcriptional activity using oestrogen, androgen, progestagen and glucocorticoid Reporter Gene Assays and on steroidogenesis using the H295R steroidogenesis model.
Methods

Chemicals and reagents
Cell culture reagents were supplied by Life Technologies (Paisley, UK). The standards 17β-oestradiol, testosterone, progesterone, hydrocortisone, monosodium glutamate and forskolin were obtained from Sigma-Aldrich (Poole, Dorset, UK). Dimethyl sulfoxide (DMSO) and MTT were also supplied by Sigma-Aldrich. Lysis reagents and A C C E P T E D M A N U S C R I P T luciferase assay system was purchased from Promega (Southampton, UK). Hoechst nuclear stain was provided by Thermo Scientific (UK). 
Cell culture
Cell viability assays
MTT assay
The MTT assay was performed to monitor the cytotoxic effects of test compounds in the RGA cell lines. Briefly, clear flat-bottomed 96-well plates (Nunc, Roskilde, Denmark) were seeded with 4 x 10 5 cells/ml of the appropriate cell line. After 24 h
MSG (0.5-500 μg/ml) was added to the cells at a final dH20 (deionised water) concentration of 0.1%. Test compounds were then incubated for 48 h. Viable cells convert the soluble yellow MTT into insoluble purple formazan by the action of mitochondrial succinate dehydrogenase. Following incubation, supernatant was discarded and 50 µl of MTT solution/well (5mg/ml stock in PBS diluted in 1:2.5 in assay media) was added and cells were incubated for a further 3 h. The supernatant was removed and 200 µl of DMSO was added to each well and incubated for 10 min with agitation at 37 °C to dissolve the formazan crystals. Optical density was measured using a Sunrise spectrophotometer at 570 nm with a reference filter at 630 nm (TECAN, Switzerland). Samples were analysed in triplicate wells and in three independent experiments. Viability was calculated as a percentage absorbance of the sample when compared with the absorbance of the solvent control ( Fig.1 ).
HCA cytotoxicity
High Content Analysis was used to assess subtle pre-lethal markers of viability in the TARM-Luc cell line. Hoechst 33342 dye at a final concentration of 1.6 µM was added to each well and incubated for 10 min at room temperature and protected from light; after which cells were washed with PBS four times and evaluated on CellInsight TM NXT High Content Screening (HCS) Platform (Thermo Fisher Scientific, UK). This instrument analyses epifluorescence of individual cell events using an automated micro-plate reader analyser interfaced with a PC (Dell precision T5600 workstation).
Hoechst stain was used to measure cell number and nuclear morphology including nuclear intensity and nuclear area. Data was captured for each plate at × 20 objective magnification in the selected excitation and emission wavelengths of Hoechst dye (Ex/Em 350/461 nm). For each well, 25 field of view images were acquired to examine each parameter ( Fig. 2 & 3) .
Reporter gene assays (RGAs)
RGAs are produced by transfecting cell lines with relevant receptors and incorporating a transactivation step with a signalling protein such as luciferase. The activation of a receptor is then measured through the signalling protein, making it possible to identify both agonism and antagonism of the specific receptor. The range of RGA cell lines used in this study were developed from human mammary gland cell lines by transformation with the luciferase gene under the control of a steroid hormone inducible promoter (Willemsen et al., 2004) . In the case of the TARM-Luc cell line, an additional vector was used (pSV-AR0 (coding for human AR)).
The RGA procedure has previously been described by Frizzell et al., (2011) . Briefly, cells were seeded at a concentration of 4 × 10 5 cells/ml, 100 µl/well in white walled, clear and flat bottomed 96-well plates (Greiner Bio-One, Fricken-hausen, Germany).
After 24 h, MSG (0.5, 5, 50, 250, 500 μg/ml MSG in dH20) and the steroid hormone 
Steroidogenesis assay
The human adrenal carcinoma cell line H295R has all the important enzymes needed for steroidogenesis and therefore can be used to investigate effects at the level of steroid hormone production. The H295R steroidogenesis assay was performed according to previously described protocols (Gracia et al., 2007; Hecker and Giesy, 2008; Frizzell et al., 2011) .
Briefly, the cells were seeded at a concentration of 3 × 10 5 cells/ml, 1 ml per well, in 24-well plates (BD Biosciences, Bedford, MA, US). The cells were allowed to attach for 24 h before removing the media and replacing with fresh media containing the test compounds dissolved in DMSO at a final concentration of 0.1% (v:v). Forskolin was used as a positive control at a concentration of 10 µM. A solvent control (0.1%, v:v DMSO in media) was also included. Subsequently, the media was collected from the wells following 48 h incubation and stored at −20 °C until hormone quantification was carried out. The 48-hour incubation time allows the concentrations of these hormones to reach a plateau-phase under these conditions. The AlamarBlue® cell viability assay was carried out on the remaining cells in each well. Each experimental point was performed in triplicate with three independent exposures (Fig.1) .
Hormone detection and quantification
Frozen media from the H295R steroidogenesis assay was thawed prior to hormone analysis. Oestradiol, testosterone and progesterone levels in the media were quantified by enzyme-linked immunosorbent assays (ELISAs) (Immunodiagnostics, Marburg, Germany). These highly specific kits are based on the principle of progesterone (0-40 ng/ml) in serum and plasma, with sensitivities of 9.714 pg/ml, 0.083 ng/ml and 0.045 ng/ml respectively. ELISA kits were carried out according to manufacturer's instructions with the exception of the standard curves which were prepared in the same culture medium used for the H295R assay. The intra-assay coefficient of variation was less than 10%. Standard curves were included on each ELISA plate. The mean absorbance obtained from each standard was plotted against its concentration using dose-response curves generated with GraphPad PRISM 5 software.
Statistical Analysis
All values shown are expressed as mean ± standard deviation (SD) of three independent exposures for the compound tested. Data from the cell viability, reporter gene and steroidogenesis assays were analysed using Microsoft Excel and GraphPad PRISM 5 software (San Diego, CA). A one-way analysis of variance (ANOVA) and
Dunnett's Multiple Comparison Test was used to determine significant differences between treatments and the corresponding controls. The mean concentrations were tested for significant difference at the 95% confidence level, a P-value of ≤0.05 was considered as significant (P≤0.05 *, P≤0.01 ** and P≤0.001 ***). Viability of the H295R cells following 48 h exposure to MSG (0.5-500 µg/ml) was investigated using the AlamarBlue® assay. Cytotoxicity was not observed at any of the concentrations tested (Fig.1) . The viability of the cells at the sample concentrations did not differ significantly from the solvent control (P > 0.05).
Results
Cell viability and cytotoxicity
In addition to the MTT assay, subtle pre-lethal markers of viability of the TARM-Luc cell line was investigated due to MSG causing a significant decrease in transcriptional activity in this cell line following exposure to 50-500 µg/ml MSG. However, no significant change in cell number, nuclear area or nuclear intensity was observed by HCA (P > 0.05) (Fig. 2 & 3) .
Reporter gene assay
No agonist response was observed for MSG at any of the test concentrations (0.5-500 µg/ml) in the MMV-Luc, TM-Luc, TGRM-Luc or TARM-Luc. Additionally, no antagonist response was seen for MSG at any of the test concentrations in the MMV-Luc, TM-Luc or TGRM-Luc cell lines. However, MSG appeared to exhibit an antagonist response in the androgen and progestagen responsive TARM-Luc cell line, with a dose dependent reduction in androgen response of 33%, 36.9% and 50.6% (in comparison to the solvent control) at 50, 250 and 500 µg/ml MSG, respectively (P ≤ 0.05) ( Fig.4) . At these concentrations of MSG no reduction in cell viability was observed in the MTT assay (Fig.1) . Additionally, as determined by HCA, the cell health markers of cell number, nuclear area and/or nuclear intensity did not significantly differ from the solvent control. Therefore these results appear to be true antagonism of the androgen receptor.
Steroidogenesis
MSG did not induce any significant changes in the production of oestradiol, testosterone or progesterone as determined by the H295R steroidogenesis assay. The mean concentration of hormones in the treated media did not differ significantly from the solvent control (P > 0.05) (Fig.5) .
Discussion
The current cellular in vitro bioassay study on MSG exposure at the level of steroid nuclear receptor signalling and steroidogenesis reports no observed effects on steroid hormone production and no (ant)agonism of the oestrogen, progestogen or glucocorticoid receptors. However, while MSG did not exhibit an agonist response in the androgen receptor, it did induce an antagonist dose dependent response in the androgen receptor. Analysis of all MSG test concentrations confirmed no assay cytotoxicity.
The androgen receptor plays an important role in regulating metabolic homeostasis and is an emerging target for diabetes and obesity. For example, it has been established that testosterone, an androgen receptor agonist, presents anti-obesity actions mediated via the androgen receptor (Mauvais-Jarvis, 2011). Clinical and epidemiological evidence also strongly indicates a major role for sex steroid hormones in the determination of anatomical specificities of fat distribution i.e. the specific region in the body where the fat accumulates, in humans (Dieudonne et al., 1998) . Adipocytes (fat cells) express the androgen receptor, suggesting that androgens may contribute to the control of adipose tissue development. Androgen receptor mRNA has been
demonstrated in human preadipocytes and adipocytes (Dieudonne et al., 1998) , with its expression increasing during adipogenesis.
Androgen receptor antagonism has also been linked to a number of detrimental health effects including influencing normal male sexual differentiation and/or fertility (Wong et al., 1995) . Men presenting genetic androgen resistance linked to CAG repeats in the androgen receptor gene, which leads to a decrease in androgen receptor-mediated gene transcription, have elevated visceral fat; indicating that a reduction in androgen receptor transcriptional activity, may encourage weight gain in the stomach area (Zitzmann et al., 2003) . Men undergoing androgen suppression treatment for prostate cancer present increased body fat mass and serum insulin (Ramasamy et al., 2012) . Additionally, clinical trials have shown reduced body fat mass during testosterone replacement therapy (Stanworth and Jones, 2010). Navarro et al., (2016) also highlight that the androgen receptor plays a role in stimulating the incretin effect of the gut hormone GLP-1 and demonstrate that androgen receptor antagonists can decrease glucose-stimulated insulin secretion. Winborn et al., (1987) showed that androgen receptors are present in the stomach and gastrointestinal tract of baboons. Therefore, antagonism of the androgen receptor by MSG may lead to obesogenic effects through disruption of metabolic homeostasis, anti-obesity protection and GLP-1 gut hormone signalling.
Steroidogenesis is a complex process regulated by numerous enzymes and genes which can be disrupted at any step (Hilscherova et al., 2004) . Each steroid hormone plays an important role in the maintenance of weight and glucose homeostasis, potentially contributing to the pathogenesis of diabetes and obesity. For example, oestradiol plays a role in regulating energy metabolism and in particular the two oestrogen receptors, ERα and ERβ (Mauvais-Jarvis, 2011). Modulation of these
receptor genes within insulin-sensitive tissues shows that oestradiol participates in glucose homeostasis (Mauvais-Jarvis, 2011). Therefore, disruption of oestradiol levels or oestrogen receptors could potentially impact upon glucose homeostasis, resulting in hyper/hypoglycaemia. Low levels of testosterone are an independent risk factor for obesity and epidemiological/clinical studies support the notion that testosterone deficiency in men leads to the development of metabolic syndrome (Stanworth and Jones, 2009 ). However, the underlying mechanism by which androgens regulate homeostasis is very complex and further exploration is required (Stanworth and Jones, 2009 ). Progesterone plays a role in both weight and glucose homeostasis with increased levels of progesterone being linked to weight gain (Galletti and Klopper, 1964; Lof et al., 2009) . Progesterone also plays a role in insulin secretion, having the ability to inhibit glucose-stimulated insulin secretion from isolated rat islets in a dosedependent manner (Straub et al., 2002) . Disruption of progesterone could potentially lead to altered insulin levels, adversely affecting blood glucose regulation increasing diabetes risk (Diabetes UK, 2015) .
In the current in vitro bioassay study, no significant difference in oestradiol, testosterone or progesterone hormone production levels were observed when compared to the controls. Similarly, an animal study whereby Wistar rats fed with MSG, also showed no significant alterations in blood testosterone and oestradiol concentrations (P > 0.05) (Ibegbulem et al., 2016) . However, other animal studies such as Nemeroff et al., (1981) and Zia et al., (2014) report alterations in oestradiol, progesterone and testosterone levels. Miskowiak et al., (1993) reported that subcutaneous perinatal administration of MSG to the rat resulted in growth inhibition, obesity, weight decrease in pituitary glands and testes plus lowered testosterone levels. Further studies in rats suggest that MSG may present effects through disruption
of steroid receptor expression and altering hormones levels such as testosterone, or progesterone. For example, neonatal rats treated orally with MSG presented decreased hypothalamic oestrogen receptor expression (Rodriguez-Sierra et al., 1982) . Upon maturation of the treated neonates, the adult rat presented altered serum levels of oestradiol and testosterone. These differing results may be due to differences between in vitro and in vivo studies, neonate or adult models, sex differences, exposure doses and duration. It is also important to note that animal studies employing subcutaneous injection of MSG are rarely applicable in human patho-toxicological investigations (Husarova and Ostatnikova, 2013) . Consequently, epidemiological studies and in vitro investigations may provide more relevant and useful findings.
Conclusion
This in vitro bioassay study shows that MSG can antagonise the androgen receptor in a dose dependent manner and highlights one possible mechanism through which MSG may exert its impact on obesity risk. Additional concerns of these findings include the potential disruption of normal male sexual differentiation and/or fertility; elevated visceral fat; dysregulation of adipose tissue development and the disturbance of antiobesity protection mediated by testosterone via the androgen receptor.
Conflict of Interest
There is no conflict of interest. Toxicological Sciences. 81:78-89 Husarova, V., and Ostatnikova, D. (2013) . Monosodium Glutamate Toxic Effects and Their Implications for Human Intake: A Review. JMED Research, 2013, 1-12. Ibegbulem, C. O., Chikezie, P. C., Ukoha, A. I., and Opara, C. N. (2016) . Effects of diet containing monosodium glutamate on organ weights, acute blood steroidal sex hormone levels, lipid profile and erythrocyte antioxidant enzymes activities of rats.
References
Journal of Acute Disease, 1-6. Janeczko, M. J., Stoll, B., Chang, X., Guan, X., and Burrin, D. G. (2007) . Extensive 
